- Home
- SOTK vs ATRA Comparison
SOTK vs ATRA Comparison
Compare SOTK & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOTK | ATRA |
|---|---|---|
| Founded | 1975 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 81.2M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SOTK | ATRA |
|---|---|---|
| Price | $5.30 | $9.55 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 32.8K | ★ 50.0K |
| Earning Date | 05-27-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.50 | ★ 122.52 |
| EPS | ★ 0.05 | N/A |
| Revenue | $20,909,315.00 | ★ $120,772,000.00 |
| Revenue This Year | $4.02 | N/A |
| Revenue Next Year | $10.95 | N/A |
| P/E Ratio | $107.00 | ★ N/A |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $3.30 | $3.92 |
| 52 Week High | $6.24 | $19.15 |
Technical Indicators
Market Signals| Indicator | SOTK | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 57.93 | 56.38 |
| Support Level | $4.77 | $9.03 |
| Resistance Level | $5.73 | $11.17 |
| Average True Range (ATR) | 0.28 | 0.72 |
| MACD | 0.03 | 0.16 |
| Stochastic Oscillator | 81.65 | 82.34 |
Price Performance
Historical ComparisonAbout SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.